Engagement of CD33 surface molecules prevents the generation of dendritic cells from both monocytes and CD34+ myeloid precursors

European Journal of Immunology

Volumn 30, Issue 3, 2000, Pages 827-833

  Ferlazzo, Guido ^a   Spaggiari, Grazia Maria ^a   Semino, Claudia ^a   Melioli, Giovanni ^a   Moretta, Lorenzo ^a,b,c  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c CENTRO DI BIOTECNOLOGIE AVANZATE   (Italy)

Author keywords

Apoptosis; CD33; Dendritic cell; Inhibitory receptor; Monocyte

Indexed keywords

CD14 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; FLT3 LIGAND; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; LIPOCORTIN 5; MONOCLONAL ANTIBODY; PROTEIN P75; STEM CELL FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BINDING AFFINITY; BONE MARROW CELL; CELL DEATH; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL SURFACE; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; NATURAL KILLER CELL; PRIORITY JOURNAL; STEM CELL;

EID: 0034001064     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200003)30:3<827::AID-IMMU827>3.0.CO;2-1     Document Type: Article

References (14)

1. Sallusto, F. and Lanzavecchia, A., Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor-alpha. J. Exp. Med. 1994. 179: 1109-1118.
2. Sallusto, F., Cella, M., Danieli, C. and Lanzavecchia, A., Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 1995. 182: 389-400.
3. + progenitors in human bone marrow. J. Immunol. 1992. 149: 2681-2688.
4. + T cells. J. Immunol. 1999. 163: 3597-3604.
5. + progenitors cells with flt3-ligand, c-kit-ligand, GM-CSF, IL-4 and TNF-α are functional antigen-presenting cells resembling mature monocyte-derived DC. J. Immunotherapy (in press).
6. Griffin, J. D., Linch, D., Sabbath, K., Larcom, P. and Schlossman, S. F., A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cells. Leuk. Res. 1984. 8: 521-534.
7. Freeman, S. D., Kelm, S., Barber, E. K. and Crocker, P. R., Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction molecules. Blood 1995. 85: 2005-2012.
8. Falco, M., Biassoni, R., Bottino, C., Vitale, M., Sivori, S., Augugliaro, R., Moretta, L., Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cells. J. Exp. Med. 1999. 190: 793-802.
9. Taylor, V. C., Buckley, C. D., Douglas, M., Cody, A. J., Simmons, D. L. and Freeman, S. D., The myeloid-specific sialic acid-binding receptor, CD33, associates with the protein-tyrosine phosphatases, SHP-1 and SHP-2. J. Biol. Chem. 1999. 274: 11505-11512.
10. Vivier, E. and Daeron, M., Immunoreceptor tyrosine-based inhibition motifs. Immunol. Today 1997. 18: 286-291.
11. Vely F., Olivero, S., Olcese, L., Moretta, A., Damen, J. E., Liu, L., Krystal, G., Cambier, J. C., Daeron, M. and Vivier, E., Differential association of phosphates with hematopoietic coreceptors bearing immunoreceptor tyrosine-based inhibition motifs. Eur. J. Immunol. 1997. 27: 1994-2000.
12. +CD33 cells influence days to engraftment and transfusion requirements in autologous blood stem-cell recipients. J. Clin. Oncol. 1998. 16: 2093-2104.
13. Vitale, C., Romagnani, C., Falco, M., Ponte, M., Vitale, M., Moretta, A., Bacigalupo, A., Moretta, L. and Mingari, M. C., Engagement of p75/AIRM1 or CD33 inhibits the proliferation of normal or leukemic myeloid cells. Proc. Natl. Acad. Sci. USA 1999. 26: 15091-15096.
14. Martin, S. J., Reutelingsperger, C. P., McGahon, A. J., Rader, J. A. van Schie, R. C., LaFace, D. M., Green, D. R., Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med. 1995. 182: 1545-1556.